GlassScriptPhysician profile
Sherry Yu
NPI 1427411149
$822.89
in general payments reported to CMS, 2019-2025
17 companies · $220 in 2025
The $220 reported for 2025 was less than what a typical Mohs-Micrographic Surgery provider received nationally (typical 2025 total: $462).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $16.75 · 2023: $135 · 2024: $451 · 2025: $220.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $806.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $806.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $136.20 | 2024-2025 | |
| Regeneron Healthcare Solutions, INC. | $107.22 | 2023-2025 | Libtayo, Dupixent |
| Regeneron Pharmaceuticals, INC. | $86.03 | 2024 | Dupixent |
| Organogenesis INC. | $73.64 | 2024-2025 | Cygnus Dual |
| Leo Pharma INC. | $67.00 | 2023-2024 | Adbry |
| Boehringer Ingelheim Pharmaceuticals, INC. | $53.35 | 2024-2025 | Spevigo |
| Janssen Biotech, INC. | $50.37 | 2023-2024 | Tremfya, Simponi Aria, Stelara |
| Amgen INC. | $43.49 | 2023-2025 | Otezla, Otezla |
| Biofrontera INC. | $40.17 | 2024 | Xepi, Bf-Rhodoled, Ameluz |
| Novartis Pharmaceuticals Corporation | $39.63 | 2024 | |
| Ucb, INC. | $29.53 | 2024 | Bimzelx |
| Convatec INC. | $18.73 | 2024 | |
| Verrica Pharmaceuticals INC. | $17.00 | 2024 | Ycanth |
| Eisai INC. | $16.75 | 2022 | |
| Conmed Corporation | $16.50 | 2023 | Airseal |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $16.48 | 2024 | |
| Organon LLC | $10.80 | 2025 | Vtama |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sherry Yu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.